Curis Lifesciences Complete Financial Statements
In FY2024, Curis Lifesciences (CURIS) reported revenue ₹9 Cr, net profit ₹1 Cr and EPS ₹24.00, with a net profit margin of 11.1% and ROE of 2.1%. Full financial statements from FY2022 to FY2026 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. View CURIS annual price range for the annual high/low range and current price position.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
CURIS Revenue, Net Profit & EBITDA — Year-on-Year Growth
CURIS YoY. For live price, earnings ratios and company overview, see CURIS screener.
CURIS Income Statement — Revenue, EBITDA & Net Profit
Curis Lifesciences revenue ₹9 Cr, EBITDA ₹3 Cr, net profit ₹1 Cr, EPS ₹24.00 (2024) — net profit margin 11.1%. Check CURIS company valuation to track the company's total market size over time.
| Particulars | Jun 2024 |
|---|---|
| Revenue | 9 |
| Expenses | 6 |
| EBITDA | 3 |
| Operating Profit Margin % | 30.00% |
| Depreciation | 0 |
| Interest | 0 |
| Profit Before Tax | 2 |
| Tax | 1 |
| Net Profit | 1 |
| Earnings Per Share (₹) | 24.00 |
CURIS Balance Sheet — Assets, Liabilities & Shareholders' Equity
CURIS total assets ₹82 Cr, total equity ₹47 Cr, total liabilities ₹ Cr (2026) — ROE 2.1%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 82 | 43 | 34 | 30 | 27 |
| Current Assets | 69 | 31 | 22 | 17 | 15 |
| Fixed Assets | 12 | 11 | 12 | 12 | 12 |
| Capital Work in Progress | 1 | 0 | 0 | 0 | 0 |
| Investments | 34 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 32 | 22 | 18 | 15 |
| LIABILITIES | |||||
| Total Liabilities | |||||
| Current Liabilities | 7 | 9 | 10 | 10 | 13 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 47 | 16 | 6 | 0 | -1 |
| Share Capital | 8 | 6 | 1 | 1 | 1 |
| Reserves & Surplus | 39 | 10 | 5 | 0 | -1 |
CURIS Cash Flow Statement — Operating, Investing & Financing
Curis Lifesciences operating cash flow ₹-2 Cr, investing ₹0 Cr, financing ₹2 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | -2 | 0 | 3 | 5 |
| Investing Activities | 0 | 0 | -1 | 0 |
| Financing Activities | 2 | 0 | -3 | -5 |
| Net Cash Flow | 0 | 0 | 0 | 0 |